Resmed Inc
SWB:RMEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
SWB:RMEA
|
US |
|
M
|
Manulife Financial Corp
XBER:MLU
|
CA |
|
Core & Main Inc
NYSE:CNM
|
US |
|
Old Mutual Ltd
LSE:OMU
|
ZA |
|
C
|
CME Group Inc
LSE:0HR2
|
US |
|
O
|
OUTsurance Group Ltd
JSE:OUT
|
ZA |
|
LG Electronics Inc
KRX:066570
|
KR |
|
F
|
Fennec Pharmaceuticals Inc
NASDAQ:FENC
|
US |
|
SGS SA
XETRA:SUV
|
CH |
|
Masimo Corp
NASDAQ:MASI
|
US |
|
Aurora Innovation Inc
NASDAQ:AUR
|
US |
|
M
|
McDonald's Corp
SWB:MDO
|
US |
Wall St Price Targets
RMEA Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RMEA is 25.09 EUR with a low forecast of 19.27 EUR and a high forecast of 30.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RMEA's stock price target?
Price Target
25.09
EUR
According to Wall Street analysts, the average 1-year price target for RMEA is 25.09 EUR with a low forecast of 19.27 EUR and a high forecast of 30.05 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.
